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Abstract
Background: Numbers of travellers visiting friends and relatives (VFRs) from Europe to malaria endemic countries
are increasing and include long-term and second generation immigrants, who represent the major burden of
malaria cases imported back into Europe. Most recommendations for malaria chemoprophylaxis lack a solid
evidence base, and often fail to address the cultural, social and economic needs of VFRs.
Methods: European travel medicine experts, who are members of TropNetEurop, completed a sequential series of
questionnaires according to the Delphi method. This technique aims at evaluating and developing a consensus
through repeated iterations of questionnaires. The questionnaires in this study included questions about
professional experience with VFRs, controversial issues in malaria prophylaxis, and 16 scenarios exploring indications
for prescribing and choice of chemoprophylaxis.
Results: The experience of participants was rather diverse as was their selection of chemoprophylaxis regimen.
A significant consensus was observed in only seven of 16 scenarios. The analysis revealed a wide variation in
prescribing choices with preferences grouped by region of practice and increased prescribing seen in Northern
Europe compared to Central Europe.
Conclusions: Improving the evidence base on efficacy, adherence to chemoprophylaxis and risk of malaria and
encouraging discussion among experts, using techniques such as the Delphi method, may reduce the variability
in prescription in European travel clinics.
Background
For most of the twentieth century, immigration from
malaria-endemic countries to Europe has been asso-
ciated with relationship between European countries
and their former colonies. Influx of immigrants has
been variable over time influenced by geography, period
of time, political stability and economic changes. Arrival
of migrants to France, Spain, Belgium and the UK, has
occurred over many decades because of their colonial
links, but migration to Italy, Greece and Eastern Eur-
opean Countries has developed more recently with a
much more ethnically heterogeneous group.
For example, because of language and cultural connec-
tions, Spain receives migrants from Latin America,
France from northern and western Africa, the UK from
Asian and Central East African Countries. Italy has
recently become a destination for migrants from many
regions in Africa, because of its proximity to North
Africa.
Many immigrants integrate into their host society and
have developed family roots, but frequently travel to
their country of origin to visit friends and relatives
(VFRs). There is now good evidence that this group of
travellers is at increased risk of acquiring infectious dis-
eases such as malaria, for a number of biological, beha-
vioural and geographical reasons [1], whereas many of
their children may be born in Europe and lack malaria
immunity.
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lower than in other groups of travellers. This and other
factors such as their health beliefs, mode and place of
travel and affordability of drugs and vaccines contribute
to their increased risk of morbidity during travel [1]. On
return, they present more frequently with severe, pre-
ventable infectious diseases than tourists [2-4]. In parti-
cular their risk of acquiring malaria appears significantly
greater, compared to other travellers [5].
The practice of advising VFRs in pre-travel clinics var-
ies throughout Europe, because of different health sys-
tems, immigrant populations and social support
structure. In a previous study, using a Delphi approach
in this group of experts, the policies of chemoprophy-
laxis recommendations in non-immune travellers varied
widely among prescribers, influenced by a high degree
of subjectivity and national policy differences [6].
The Delphi approach is a consensus development
technique, which was introduced in 1952, to be used in
situations where, in absence of scientific evidence, there
is no unanimity of opinion [7-9]. Experts’ views are
explored to examine the range of policies followed in
practice, through an iterative completion of question-
naires along with cumulative feedback [10]. The aim of
this study was to investigate the opinions of major Eur-
opean experts, and to identify their degree of consensus
when dealing with malaria prevention in VFRs.
Methods
This study was undertaken in the framework of Trop-
NetEurop, a European network of travel and tropical
medicine centres, created to report cases of imported
infections, exchange opinions and improve practice
among professionals [11-13]. An initial study, focused
on malaria chemoprophylaxis in all groups of travellers
was published elsewhere [6]. In this paper, a follow-on
study, designed to examine the experts’ practices in
advising VFRs travellers, is reported. Six experts in tra-
vel medicine, belonging to TropNetEurop and recog-
nized as leaders in this field, prepared, discussed and
designed the questionnaire. Following pilot testing the
questionnaire was forwarded for completion to lead
clinician in all network member sites (designated in the
manuscript as “experts”).
The first questionnaire (see additional file 1) examined
the respondent’s experience with VFRs, and problems
encountered in prescribing malaria prophylaxis to this sub-
set of travellers. Each question included a number of
choices, and responses were based on a on a visual scale
between 1 and 10. The responses were analysed as median
and 1
st-3
rd quartile difference. Some questions with a single
numerical response were evaluated as means or medians.
The second part of the questionnaire investigated pre-
scribing preferences for 16 travel scenarios (see additional
file 2): participants chose their preferred chemoprophy-
laxis recommendations and gave reasons for this choice.
Agreement was evaluated by the use of a homogeneity
index for categorical variables, scoring 0 for no consensus
(i.e. equal distribution throughout the three response
choices: yes, no, uncertain) to 1 for complete consensus
[14]. All results were captur e du s i n gM i c r o s o f tE x c e l
©.
The survey was undertaken between May and September
2006.
Results
Forty-seven questionnaires were distributed and 25
(53.1%) were returned and were evaluable. The geo-
graphic distribution of responding centres reflected the
distribution of TropNetEurop centres (five in Germany,
four in Italy, two in Denmark, Portugal, Spain and Swit-
zerland, one each in Belgium, Finland, France, Ireland,
Norway, Poland, Sweden and the UK).
VFR travellers make up a minority of attendees at
most sites surveyed (less than 15% in 19 clinics and
more than 35% in only two, Paris and Copenhagen).
The majority of VFRs originate from West Africa, and
the remainder from other parts of Africa. Only a minor-
ity were from the Indian Sub Continent or Latin Amer-
ica. Responses of experts to most questions are shown
as median and interquartile differences in Figure 1.
The majority of respondents (17/25) recommended
different prophylaxis regimens for VFRs than for other
travellers, but 12 respondents would use the same
recommendation after the immigrant has been resident
for one to five years in the host country. Half of the
experts (13/25) modified their advice where the traveller
was accompanied by children. The proportion of VFR
patients admitted with malaria on return from travelling
was 43% of all malaria admissions (median; range:
10-85%).
The results of the second part of the questionnaire
(scenarios) are shown in Figure 2. Experts’ affirmative
responses to chemoprophylaxis across the 16 scenarios
ranged between three and 15. Prescribers from Northern
Europe gave an affirmative response in 12.5 scenarios
( m e a n ) ,w h i l et h o s ef r o mC e n t r a lE u r o p eo n l yi n
9.4. The difference at Student’s t test is significant
(p = 0.02). Prescribers from Southern Europe answered
yes in 11.5 cases (non-significant versus other groups).
Nine of the scenarios were very similar to those exam-
ined by the experts in the previous study and now
referred to as non-VFRs [6]. A comparison of the
recommendations given to VFRs and non-VFRs on the
same scenarios is shown in Figure 3.
Discussion
T h i ss t u d yw a saf o l l o wo nf r o map r e v i o u ss t u d y[ 6 ]
investigating European experts’ opinions on malaria
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the present study, the experts were TropNetEurop cen-
tre managers: 19 experts took part in both studies.
Although VFR travellers to different parts of the world
have different malaria risk profiles, the first part of the
questionnaire explored the philosophy when advising
and examined differences in advice to VFRs and non-
VFR travellers, but did not account for the heterogeneity
of these populations due to other risk factors including
destination and age. This aspect was explored in the
second part of the questionnaire, where specific situa-
tions were examined. We identified variability in opi-
nions, relating to numbers of VFRs seen in clinic,
country or origin of this population and usage of travel
clinic services. This probably reflects the varied national
ĂͿ
ďͿ
ĐͿ
ĚͿ
ĞͿ
Figure 1 Questionnaire section A: scores given by the experts
to questions. Median and interquartile differences of scores given
by the experts to questions n. 1, 2, 3, 8, 10, 11 (see additional file 1).
In graphs d) and e), the answers were compared to what the same
experts responded to a previous questionnaire on non-VFR travellers
[6].
Figure 2 Questionnaire section B: Responses of expert to
single scenarios. For everyone of the 16 scenarios the proportion
of experts recommending prophylaxis (green bar) not
recommending prophylaxis (red bar) or uncertain (yellow bar) is
reported. For details about the scenarios, see additional file 2.
Figure 3 Prophylaxis prescription in the proposed scenarios:
non-VFRs and VFRs. Comparison between scenarios referred to
non-VFRs (in a previous questionnaire [6]) and VFRs. Only 9 similar
scenarios and only answers by experts who have responded to
both questionnaires are included.
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of immigration. Although VFRs make up a significant
burden of imported malaria throughout Europe [15],
they appear to represent a low proportion of travel
clinic clients. This can be interpreted in a number of
ways. They may reflect that this group is a low propor-
tion of all travellers, but has increased malaria risk.
VFRs may not perceive themselves to at risk of malaria
and therefore not seek advice: a few studies have
described VFRs malaria risk perception and use of pro-
phylaxis when returning to their home countries
[16-18]. VFRs may encounter barriers such as lack of
information of services, language, trust of health sys-
tems, concerns on their legal status, and cost, which
may limit their access to travel clinics [2]. Cost benefit
modelling of the financial benefit of subsidising chemo-
prophylaxis for VFRs in France [19] and Switzerland
[20] suggests that such a subsidy by the health/insurance
provider is cost effective and would save money. Over-
coming barriers encountered by VFRs would require
combined efforts of professionals, policy makers, leaders
in the communities and support from non-profit charity
organizations. Factors that influence prophylaxis pre-
scribing by experts were similar for tourists and VFRs
(geographic area, duration, itinerary, compliance), but
educational level was considered important when pre-
scribing for the latter.
There was no consensus among experts regarding
modifying chemoprophylaxis regimens for their VFR cli-
ent, but the majority attempted to reduce cost and
improve adherence. There are significant costs variations
among regimens and for VFRs, who often have low
income and stay abroad for longer, choosing the least
expensive was an important option and influenced pre-
scribing. There was no consensus on when an immigrant
becomes more vulnerable or can be considered as a non-
immune. Some authors suggest that ‘semi-immunity’
may last longer (more than four or five years) than has
been commonly assumed [21-23]. Mascarello and collea-
gues report that settled migrants not exposed to malaria
for more than eight years develop more severe malaria
than those recently arrived [24]. Some respondents
altered their prescribing to VFRs when they are accompa-
nied by children (who are likely to be non-immune), in
order to provide a single regimen for the whole family,
and attempt to improve adherence.
The scenarios highlighted diverse chemoprophylaxis
prescribing among experts by geographic regions within
Europe. Northern European experts were more likely to
recommend prophylaxis than Central Europeans. This
may reflect differences of national guidelines, training,
availability of drugs and experience of VFR travellers.
Comparing nine similar scenarios used in the initial sur-
vey [6] the differences in prophylaxis recommendations
between VFRs and non-VFRs can be observed. Chemopro-
phylaxis was recommended less frequently for VFRs (in
eight out of nine scenarios), and uncertainty in prescribing
w a sm o r ef r e q u e n t l ye x p r e ssed in this group (9.3% in
VFRs vs. 5.8%). Explanations for this would include afford-
ability of drugs and expected lack of adherence to
prophylaxis.
Overall the study found a very low consensus in 5/16
scenarios and a low consensus, in a further 4/16 scenar-
ios. Insufficient consensus in more than half of the sce-
narios suggests that opinion rather than evidence was
used when deciding risk and indications, and highlights
a deficit of evidence. Good evidence would also improve
consistency of guidelines across Europe (Figure 4).
Conclusions
VFRs have the highest proportion of malaria morbidity:
addressing their needs and requirements is a priority.
This study supports findings from the previous study
within the same group of experts. There is a consider-
able variation in recommendations for malaria prophy-
laxis among professionals in Europe, both from a
conceptual perspective, and in prescribing practice
when assessed though responses to clinical scenarios.
This may be due to insufficient detail provided in the
scenarios or may be related to the heterogeneity of
national guidelines across Europe. The most likely
explanation is poverty of evidence on efficacy, adher-
ence to medication and malaria risk faced by travellers,
and in particular, evidence pertaining to VFRs. This
lack of evidence results in recommendations largely
based on personal opinion, particularly in specialist
referral centres. Understanding frequency of adverse
events, knowledge, adherence and behaviour of VFR tra-
vellers and opinion of health professionals could help
Figure 4 Homogeneity index in answers proposed by experts
to the 16 scenarios. The homogeneity index for categorical
variables ranges from 0 (no consensus, i.e equal distribution
throughout the three response choices: yes, no, uncertain) to 1
(complete consensus on one choice). For details about the
scenarios, see additional file 2.
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the incidence of malaria in VFR travellers.
Additional material
Additional file 1: Questionnaire part A. Please answer the following
questions, about your experience with immigrants to Europe, returning
to their Country of origin to visit friends and relatives ("VFR”).
Additional file 2: Questionnaire part B. Please find 16 practical cases
described below. For every case state if you would recommend
chemoprophylaxis (yes/no/uncertain), which chemoprophylaxis (if yes),
and possibly why
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